Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rigel Pharmaceuticals
(NQ:
RIGL
)
13.45
+0.97 (+7.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rigel Pharmaceuticals
< Previous
1
2
3
4
5
Next >
Rigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pact
August 03, 2022
Via
Benzinga
Rigel Pharmaceuticals: Q2 Earnings Insights
August 02, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Outlook For Rigel Pharmaceuticals
August 01, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Rigel...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
June 27, 2022
Gainers
Via
Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
June 24, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
June 23, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
Via
Benzinga
63 Biggest Movers From Yesterday
June 17, 2022
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the...
Via
Benzinga
3 Stocks Under $1 Insiders Are Buying
June 14, 2022
The Nasdaq Composite dropped by more than 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022
June 09, 2022
Upgrades
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 09, 2022
Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
June 09, 2022
Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.
Via
Benzinga
83 Biggest Movers From Yesterday
June 09, 2022
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...
Via
Benzinga
Mid-Afternoon Market Update: Dow Tumbles 300 Points; HeartCore Enterprises Shares Spike Higher
June 08, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dipping over 300 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 08, 2022
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 1%; Rigel Pharmaceuticals Shares Slide
June 08, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite adding around 50 points on Wednesday.
Via
Benzinga
Why Rigel Pharmaceuticals Shares Are Falling Today
June 08, 2022
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares are trading lower after the company announced data from the FORWARD Phase 3 clinical trial of Fostamatinib did not demonstrate statistical significance...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022
June 08, 2022
Upgrades
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
June 08, 2022
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.
Via
Benzinga
Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial
June 08, 2022
Rigel Pharmaceuticals Inc (NASDAQ: RIGL) shares are falling on disappointing data from the FORWARD Phase 3 trial of fostamatinib in patients with warm autoimmune hemolytic anemia (wAIHA).
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 07, 2022
Good morning! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
On Wednesday, 73 stocks hit new 52-week lows.
Via
Benzinga
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
May 24, 2022
Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 03, 2022
Gainers
Via
Benzinga
Recap: Rigel Pharmaceuticals Q1 Earnings
May 03, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Preview: Rigel Pharmaceuticals's Earnings
May 02, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel...
Via
Benzinga
Earnings Scheduled For May 3, 2022
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.